Nicergoline

尼麦角林

Report date: 2024/01/11 16:14:03
NME

Base Information

Drug NameNicergoline
Drug Alias Name麦角溴烟酯尼什枸宁富路通尼舒雅润基 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonists
TargetsAdrenergic receptors
Therapy Area/IndicationsAffective Disorders, PsychoticMood DisordersDizziness +[7] 
Global Approved IndicationsMood DisordersPeripheral Vascular Diseases
Approved Indications in ChinaMood DisordersPeripheral Vascular Diseases
Original Approved Country/TerritoryN/A
Original Approved Date1974/01/01
Country/TerritoryThailandSouth KoreaMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSilpakorn UniversityPharmacia & Upjohn SpaEthypharm Sa +[5] 
Inactive CompaniesViatris
Active IndicationsAffective Disorders, PsychoticMood DisordersDizziness +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeC04AE02
Related LinksWikipediaDrugBankKEGG